These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22375166)

  • 41. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.
    Jensen NW; Clemmensen KKB; Jensen MM; Pedersen H; Færch K; Diaz LJ; Quist JS; Størling J
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Satiety and gastrointestinal hormones during a Mixed Meal Tolerance Test after gastric bypass surgery: association with plasma amino acid concentrations.
    van den Broek M; de Heide LJM; Emous M; Wijma RB; Veeger NJGM; Wolthuis A; Laskewitz AJ; Heiner-Fokkema MR; Muller Kobold AC; Wolffenbuttel BHR; van Beek AP
    Surg Obes Relat Dis; 2018 Aug; 14(8):1106-1117. PubMed ID: 29937240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?
    Lean ME; Malkova D
    Int J Obes (Lond); 2016 Apr; 40(4):622-32. PubMed ID: 26499438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
    Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A
    Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
    Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of meal size on the release of GLP-1 and PYY after Roux-en-Y gastric bypass surgery in obese subjects with or without type 2 diabetes.
    Yan W; Polidori D; Yieh L; Di J; Wu X; Moreno V; Li L; Briscoe CP; Shankley N; Dohm GL; Pories WJ
    Obes Surg; 2014 Nov; 24(11):1969-74. PubMed ID: 24972682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity.
    Näslund E; Grybäck P; Hellström PM; Jacobsson H; Holst JJ; Theodorsson E; Backman L
    Int J Obes Relat Metab Disord; 1997 May; 21(5):387-92. PubMed ID: 9152741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GLP-1 and PYY
    Dischinger U; Corteville C; Otto C; Fassnacht M; Seyfried F; Hankir MK
    Surg Obes Relat Dis; 2019 Sep; 15(9):1483-1492. PubMed ID: 31548004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism.
    Grunddal KV; Ratner CF; Svendsen B; Sommer F; Engelstoft MS; Madsen AN; Pedersen J; Nøhr MK; Egerod KL; Nawrocki AR; Kowalski T; Howard AD; Poulsen SS; Offermanns S; Bäckhed F; Holst JJ; Holst B; Schwartz TW
    Endocrinology; 2016 Jan; 157(1):176-94. PubMed ID: 26469136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity.
    Odunsi ST; Vázquez-Roque MI; Camilleri M; Papathanasopoulos A; Clark MM; Wodrich L; Lempke M; McKinzie S; Ryks M; Burton D; Zinsmeister AR
    Obesity (Silver Spring); 2010 Aug; 18(8):1579-84. PubMed ID: 19960001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review.
    Beckman LM; Beckman TR; Earthman CP
    J Am Diet Assoc; 2010 Apr; 110(4):571-84. PubMed ID: 20338283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut hormones and the control of appetite.
    Small CJ; Bloom SR
    Trends Endocrinol Metab; 2004 Aug; 15(6):259-63. PubMed ID: 15358278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of peptide YY in 5-fluorouracil-induced reduction of dietary intake.
    Sakai H; Kai Y; Takase K; Sato K; Kimura M; Tabata S; Yaegashi M; Sato F; Yomoto T; Narita M
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):753-9. PubMed ID: 27130783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass.
    de Hollanda A; Casals G; Delgado S; Jiménez A; Viaplana J; Lacy AM; Vidal J
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4677-84. PubMed ID: 26505823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. News in gut-brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery?
    Hanusch-Enserer U; Roden M
    Eur J Clin Invest; 2005 Jul; 35(7):425-30. PubMed ID: 16008543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Appetite-Regulating Hormones in Human Milk: A Plausible Biological Factor for Obesity Risk Reduction?
    Larson-Meyer DE; Schueler J; Kyle E; Austin KJ; Hart AM; Alexander BM
    J Hum Lact; 2021 Aug; 37(3):603-614. PubMed ID: 33030994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells.
    Habib AM; Richards P; Rogers GJ; Reimann F; Gribble FM
    Diabetologia; 2013 Jun; 56(6):1413-6. PubMed ID: 23519462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss.
    Reinehr T; Roth CL; Schernthaner GH; Kopp HP; Kriwanek S; Schernthaner G
    Obes Surg; 2007 Dec; 17(12):1571-7. PubMed ID: 18046613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.
    Holst JJ; Madsbad S; Bojsen-Møller KN; Svane MS; Jørgensen NB; Dirksen C; Martinussen C
    Surg Obes Relat Dis; 2018 May; 14(5):708-714. PubMed ID: 29776493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.